Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen
Status:
Completed
Trial end date:
2015-07-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the outcomes of different treatment methods including
photodynamic therapy (PDT), intravitreal ranibizumab injection (IVR) and combination therapy
under the "1+PRN" treatment regimen for polypoidal choroidal vasculopathy (PCV) and find the
optimal treatment for PCV.